Activest Wealth Management’s Akebia Therapeutics AKBA Stock Holding History

Activest Wealth Management’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.28K	Hold	2,000	–	–	﹤0.01%	834
2026 Q1	$2.78K	Hold	2,000	–	–	﹤0.01%	912
2025 Q4	$3.22K	Hold	2,000	–	–	﹤0.01%	826
2025 Q3	$5.46K	Hold	2,000	–	–	﹤0.01%	625
2025 Q2	$7.28K	Hold	2,000	–	–	﹤0.01%	492
2025 Q1	$3.84K	Hold	2,000	–	–	﹤0.01%	545
2024 Q4	$3.8K	Hold	2,000	–	–	﹤0.01%	391
2024 Q3	$2.64K	Hold	2,000	–	–	﹤0.01%	410
2024 Q2	$2.04K	Buy	+2,000	New	+$2.47K	﹤0.01%	399

Other funds holding AKBA

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

IWN

Independent Wealth Network Urbandale, Iowa $393M AUM 30.08% 1-Year Est. Return

LPT

Legacy Private Trust Neenah, Wisconsin $1.81B AUM 19.87% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

EWS

Eagle Wealth Strategies West Deptford, New Jersey $262M AUM 31.52% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Activest Wealth Management's AKBA Position: Q2 2026 in Review

Activest Wealth Management held its Akebia Therapeutics (AKBA) position steady in Q2 2026 at 2,000 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Activest Wealth Management first reported a position in AKBA in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.28K in Q2 2025. 15 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

Activest Wealth Management held 2,000 shares of Akebia Therapeutics worth $2.28K as of Q2 2026.
Activest Wealth Management left its Akebia Therapeutics share count unchanged in Q2 2026.
Akebia Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #834 holding.
Activest Wealth Management first reported a position in Akebia Therapeutics in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Akebia Therapeutics position peaked at $7.28K in Q2 2025.
15 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.